Skip to main content
logo
Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.56
-0.17 (-1.58%)
Aug 27, 2026, 4:08 PM HKT

Xuanzhu Biopharmaceutical Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Market Capitalization
5,55836,515----
Market Cap Growth
------
Enterprise Value
4,97136,396----
Last Close Price
10.7370.50----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
PS Ratio
46.59633.81----
PB Ratio
3.7223.95----
P/TBV Ratio
7.8631.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
EV/Sales Ratio
41.67631.74----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Debt / Equity Ratio
000.000.020.020
Net Debt / Equity Ratio
-0.39-0.48-0.26-0.39-0.68-0.71
Net Debt / EBITDA Ratio
2.953.170.461.373.024.29
Net Debt / FCF Ratio
-3.101.923.682.473.62
Asset Turnover
0.080.040.02---
Inventory Turnover
1.040.360.26---
Quick Ratio
2.733.041.453.2419.9514.26
Current Ratio
3.693.752.063.7921.2814.95
Return on Equity (ROE)
-19.61%-21.10%-53.84%--29.47%-16.87%
Return on Assets (ROA)
-9.64%-10.28%-27.99%--15.83%-14.54%
Return on Capital Employed (ROCE)
-15.00%-16.50%-55.40%-28.80%-23.00%-17.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Earnings Yield
-4.36%-0.75%----
FCF Yield
--0.64%----
Buyback Yield / Dilution
-9.66%-3.15%--14.22%--